171 related articles for article (PubMed ID: 21155084)
1. A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis.
Poulin Y; Papp KA; Wasel NR; Andrew R; Fraquelli E; Bernstein G; Chan D
Int J Dermatol; 2010 Dec; 49(12):1368-75. PubMed ID: 21155084
[TBL] [Abstract][Full Text] [Related]
2. Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.
Poulin Y; Wasel N; Chan D; Bernstein G; Andrew R; Fraquelli E; Papp K
Can Fam Physician; 2012 Jul; 58(7):e390-400. PubMed ID: 22859642
[TBL] [Abstract][Full Text] [Related]
3. A Canadian self-administered online survey to evaluate the impact of moderate-to-severe psoriasis among patients.
Wasel N; Poulin Y; Andrew R; Chan D; Fraquelli E; Papp K
J Cutan Med Surg; 2009; 13(6):294-302. PubMed ID: 19919806
[TBL] [Abstract][Full Text] [Related]
4. Satisfaction with treatment among patients with psoriasis: a web-based survey study.
van Cranenburgh OD; de Korte J; Sprangers MA; de Rie MA; Smets EM
Br J Dermatol; 2013 Aug; 169(2):398-405. PubMed ID: 23565643
[TBL] [Abstract][Full Text] [Related]
5. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey.
Horn EJ; Fox KM; Patel V; Chiou CF; Dann F; Lebwohl M
J Am Acad Dermatol; 2007 Dec; 57(6):957-62. PubMed ID: 17706322
[TBL] [Abstract][Full Text] [Related]
6. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011.
Armstrong AW; Robertson AD; Wu J; Schupp C; Lebwohl MG
JAMA Dermatol; 2013 Oct; 149(10):1180-5. PubMed ID: 23945732
[TBL] [Abstract][Full Text] [Related]
7. Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice.
Duffin KC; Yeung H; Takeshita J; Krueger GG; Robertson AD; Troxel AB; Shin DB; Van Voorhees AS; Gelfand JM
Br J Dermatol; 2014 Mar; 170(3):672-680. PubMed ID: 24266717
[TBL] [Abstract][Full Text] [Related]
8. Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users.
Ighani A; Yu AM; Sandhu VK; Barankin B; Manolson MF
J Cutan Med Surg; 2019; 23(2):148-156. PubMed ID: 30801221
[TBL] [Abstract][Full Text] [Related]
9. Patient satisfaction with current psoriasis treatment: a real-world study in the USA.
Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E
Dermatol Online J; 2016 Feb; 22(2):. PubMed ID: 27267186
[TBL] [Abstract][Full Text] [Related]
10. Defining and treating moderate plaque psoriasis: a dermatologist survey.
Knuckles MLF; Levi E; Soung J
J Dermatolog Treat; 2018 Nov; 29(7):658-663. PubMed ID: 29502473
[TBL] [Abstract][Full Text] [Related]
11. Characterizing Outcomes and Unmet Needs Among Patients in the United States with Mild-to-Moderate Plaque Psoriasis Using Prescription Topicals.
Gupta S; Garbarini S; Nazareth T; Khilfeh I; Costantino H; Kaplan D
Dermatol Ther (Heidelb); 2021 Dec; 11(6):2057-2075. PubMed ID: 34648148
[TBL] [Abstract][Full Text] [Related]
12. The burden of psoriasis and barriers to satisfactory care: results from a Canadian patient survey.
Mahler R; Jackson C; Ijacu H
J Cutan Med Surg; 2009; 13(6):283-93. PubMed ID: 19919805
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of moderate-to-severe plaque psoriasis in a Canadian surveyed population.
Papp K; Valenzuela F; Poulin Y; Bernstein G; Wasel N
J Cutan Med Surg; 2010; 14(4):167-74. PubMed ID: 20642985
[TBL] [Abstract][Full Text] [Related]
14. Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
Tveit KS; Duvetorp A; Ăstergaard M; Skov L; Danielsen K; Iversen L; Seifert O
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):340-354. PubMed ID: 30242921
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting.
Takeshita J; Callis Duffin K; Shin DB; Krueger GG; Robertson AD; Troxel AB; Van Voorhees AS; Gelfand JM
J Am Acad Dermatol; 2014 Oct; 71(4):633-41. PubMed ID: 24928705
[TBL] [Abstract][Full Text] [Related]
16. Patient preferences for psoriasis treatments: impact of treatment experience.
Schaarschmidt ML; Umar N; Schmieder A; Terris DD; Goebeler M; Goerdt S; Peitsch WK
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):187-98. PubMed ID: 22225546
[TBL] [Abstract][Full Text] [Related]
17. Biologic Therapy Utilization in Patients With Moderate to Severe Psoriasis and Psoriatic Arthritis: An Observational Summary of Biologic Therapy Use in a Clinical Setting.
Gulliver WP; Randell S; Gulliver S; Gregory V; Nagle S; Chambenoit O
J Cutan Med Surg; 2018; 22(6):567-576. PubMed ID: 29952225
[TBL] [Abstract][Full Text] [Related]
18. Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis.
Chung J; Callis Duffin K; Takeshita J; Shin DB; Krueger GG; Robertson AD; Troxel AB; Van Voorhees AS; Edson-Heredia E; Gelfand JM
J Am Acad Dermatol; 2014 Oct; 71(4):623-32. PubMed ID: 24894455
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents.
Ighani A; Partridge ACR; Shear NH; Lynde C; Gulliver WP; Sibbald C; Fleming P
J Cutan Med Surg; 2019; 23(2):204-221. PubMed ID: 30463416
[TBL] [Abstract][Full Text] [Related]
20. Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER).
Lambert J; Ghislain PD; Lambert J; Cauwe B; Van den Enden M
J Dermatolog Treat; 2017 Aug; 28(5):394-400. PubMed ID: 27791446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
